Mabtas 100 mg Injection
96,50$
53,12$
Mabtas 100 mg injection is a targeted monoclonal antibody therapy designed to address various immune-related conditions, particularly in oncology. This innovative treatment is primarily utilized for managing specific types of cancers, such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia, by effectively modulating the immune response against malignant cells. By binding to particular proteins on the surface of cancerous B cells, Mabtas helps to inhibit their growth and promotes their destruction by the body’s immune system. While it offers significant therapeutic benefits, patients should be aware of potential side effects, including infusion reactions and an increased risk of infections, which necessitate careful monitoring during treatment. It is crucial to consult healthcare professionals for a comprehensive understanding of its use, dosing, and any necessary precautions. This medication exemplifies the advancement in cancer therapies, providing hope to those battling these challenging conditions. Always discuss with your healthcare provider to determine if Mabtas is the right choice for your treatment plan.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Mabtas 100 mg injection is primarily used in the treatment of non-Hodgkin lymphoma (NHL), a type of cancer that affects the lymphatic system. This medication helps in targeting and destroying cancerous cells, providing a crucial option for patients. It is often administered as part of a comprehensive treatment plan tailored to individual patient needs. The effectiveness of Mabtas in managing NHL can significantly improve patient outcomes.
• Another significant application of Mabtas 100 mg injection is in the management of rheumatoid arthritis. This chronic inflammatory condition affects the joints and can lead to severe pain and disability. Mabtas works by modulating the immune response, helping to reduce inflammation and improve joint function. Patients receiving Mabtas often experience relief from symptoms and an enhanced quality of life.
• Mabtas 100 mg injection is also indicated for the treatment of chronic lymphocytic leukaemia, a type of blood cancer characterized by the accumulation of abnormal white blood cells. The medication plays a vital role in controlling the progression of the disease. By targeting specific cells, Mabtas helps to reduce the overall burden of cancer in the body. This targeted approach can lead to more favorable treatment outcomes for patients.
• Additionally, Mabtas 100 mg injection is utilized in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis, both of which are autoimmune conditions. These disorders can cause inflammation in various organs, leading to serious health complications. Mabtas helps by suppressing the inappropriate immune response, thereby alleviating symptoms and preventing further damage. The use of Mabtas in these conditions underscores its versatility in treating complex medical issues.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Mabtas 100 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician.
Rheumatoid arthritis: Mabtas 100 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician.
Blood cancer (chronic lymphocytic leukemia): Leukemia, also known as blood cancer, is a malignant neoplasm of the hematopoietic tissues that impairs the body's ability to combat infection. Mabtas 100 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment.
Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Mabtas 100 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA.
Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Mabtas 100 mg Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Mabtas 100 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Mabtas 100 Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Mabtas 100 mg. Please consult your doctor.
• Kidney: Mabtas 100 mg Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Mabtas 100 mg Injection is likely to be safe to use while breastfeeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Mabtas 100 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Mabtas 100 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Mabtas 100 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.